Early Prognostic Factors in Multiple Sclerosis: Clinical and Therapeutic Implications
Medicina · 02.03.2026 · 62 (3) · 475
DOI: 10.3390/medicina62030475 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Medicina, online erschienen am 02.03.2026. Verfasst von Katarzyna Maciejowska-Szydło und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Health Sciences in Katowice, Medical University of Silesia, 40-635 Katowice, Poland. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.
Abstract (Originalsprache)
Introduction
Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system with a highly heterogeneous clinical course. Early identification of patients at risk of aggressive disease progression is crucial for optimizing therapeutic strategies, including eligibility for highly effective treatments.
Objective
The aim of this review was to synthesize current data on prognostic factors in multiple sclerosis, with particular emphasis on their significance in the early stages of the disease and potential clinical implications.
Methods
A narrative systematic review of the literature was conducted, including observational studies, cohort studies, meta-analyses, and systematic reviews on the natural course of MS, prognostic factors, and clinical, neuroimaging, and laboratory biomarkers. We comprehensively reviewed PubMed and Scopus databases, focusing on English-language publications. Study selection prioritized longitudinal studies and meta-analyses with clear outcome definitions and sufficient follow-up. Formal quality scoring was not applied due to the narrative design of the review.
Results
Key adverse prognostic factors include older age at onset, polysymptomatic onset, high relapse activity in the first years, incomplete remission after relapses, and the primary progressive form. Magnetic resonance imaging features, including the number and location of T2 lesions, contrast activity, the presence of spinal cord lesions, PRLs and SELs, and severe brain atrophy, also have significant predictive value. Increasing importance is being attached to laboratory biomarkers, such as oligoclonal bands, light neurofilaments, free kappa light chains, and GFAP.
Conclusions
An integrated assessment of clinical, neuroimaging, and laboratory factors enables more effective risk stratification in patients with newly diagnosed MS. Early identification of an unfavorable prognostic profile may provide a basis for individualizing treatment and considering the use of highly effective therapies early in the course of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Health Sciences in Katowice, Medical University of Silesia, 40-635 Katowice, Poland.
ORCID-Profile: Przemysław Puz
Förderung
- Medical University of Silesia
Zitieren
APA
Maciejowska-Szydło, K., & Puz, P. (2026). Early Prognostic Factors in Multiple Sclerosis: Clinical and Therapeutic Implications. Medicina, 62(3), 475. https://doi.org/10.3390/medicina62030475
Vancouver
Maciejowska-Szydło K, Puz P. Early Prognostic Factors in Multiple Sclerosis: Clinical and Therapeutic Implications. Medicina. 2026;62(3):475. doi:10.3390/medicina62030475
BibTeX
@article{MaciejowskaSzydo2026,
author = {Maciejowska-Szydło, Katarzyna and Puz, Przemysław},
title = {Early Prognostic Factors in Multiple Sclerosis: Clinical and Therapeutic Implications},
journal = {Medicina},
year = {2026},
volume = {62},
number = {3},
pages = {475},
doi = {10.3390/medicina62030475}
}
EUVIMED